Hydrogen-Generating Compound Combinations for Inflammation Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current anti-inflammatory and pain relief medications, such as steroids and NSAIDs, come with significant adverse side effects, and while gabapentin and its successor pregabalin provide efficacy, they still have side effects like dizziness and withdrawal issues, necessitating a more effective and safer alternative.
Innovation Solution
A composition combining a hydrogen-generating compound, like lactulose, with anti-inflammatory agents like pregabalin or ibuprofen, to increase hydrogen levels in the body, synergistically reducing inflammation and pain while minimizing side effects by lowering the required doses of these agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If steroids or NSAIDs are used to treat inflammation, then anti-inflammatory effect is improved, but adverse side effects increase
Solution Approach 1:
The patent introduces hydrogen as an intermediary substance that mediates between the anti-inflammatory need and side effect reduction. Hydrogen acts as a selective antioxidant that neutralizes harmful reactive oxygen species while protecting beneficial oxidative processes, thereby providing anti-inflammatory effects without the harmful side effects of traditional agents like steroids and NSAIDs
Solution Approach 2:
The patent changes the chemical parameter approach from using complex pharmaceutical compounds (steroids, NSAIDs) to using simple molecular hydrogen (H2). This parameter change involves shifting from high-molecular-weight drugs with multiple functional groups to a diatomic molecule that provides anti-inflammatory effects through a different mechanism (selective antioxidant activity), thereby reducing side effects
2Reliability
If gabapentin or pregabalin are used to relieve pain, then pain relief efficacy is improved, but side effects such as dizziness and withdrawal symptoms occur
Solution Approach 1:
The patent extracts and isolates the beneficial anti-inflammatory and analgesic effects from the harmful side effects by using hydrogen therapy. Instead of using gabapentin or pregabalin which produce both therapeutic effects and neurological side effects, the patent applies hydrogen to achieve similar pain relief through antioxidant and anti-inflammatory mechanisms without affecting the central nervous system directly
Solution Approach 2:
The patent employs molecular hydrogen, a simple and inexpensive diatomic molecule, as a temporary but effective therapeutic agent. Hydrogen provides acute anti-inflammatory and analgesic effects through its antioxidant properties, then is naturally exhaled from the body without accumulation, avoiding the withdrawal symptoms associated with longer-acting drugs like gabapentin and pregabalin
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The combination effectively reduces inflammation and pain with lower doses of anti-inflammatory agents, minimizing side effects such as dizziness and withdrawal symptoms, and demonstrates additive effects in suppressing pain-related factors like Substance P and nerve growth factor.
Implementation Method 1
lactulose, a hydrogen-generating compound
Data Source
AI summary
A composition for treating inflammation and pain, including a hydrogen-generating compound in an amount that increases the amount of hydrogen in an individual and has an anti-inflammatory effect. A composition for treating inflammation and pain, including synergistically effective amounts of pregabalin and lactulose. A method of treating inflammation and pain, by administering a composition comprising a hydrogen-generating compound to an individual in an amount that increases the amount of hydrogen in the individual and has an anti-inflammatory effect.